Single-cell CyTOF analysis uncovers changes in B, T, and macrophage populations in aging mouse liver - Report - MDSpire

Single-cell CyTOF analysis uncovers changes in B, T, and macrophage populations in aging mouse liver

  • By

  • Zheng Ding

  • Bing Fang

  • Jing Peng

  • Siyu Wang

  • Xiaomin Tian

  • Guixi Chen

  • Yuqiu Wei

  • Yuebin Gao

  • Yixuan Li

  • Jiazeng Sun

  • April 28, 2026

  • 0 min

Share

Clinical Report: Single-cell CyTOF analysis of aging mouse liver immune cells

Overview

This study reveals significant age-related changes in hepatic immune cell populations in mice, highlighting a reduction in IgD+ B cells and an expansion of various CD4+ T cell subsets and pro-inflammatory M1 macrophages. These findings provide insights into the immune dysregulation associated with aging and its implications for chronic liver diseases.

Background

Population aging is linked to increased risks of chronic liver diseases due to immune dysregulation. The liver plays a vital role in immune response and metabolism, and understanding how its immune landscape changes with age is crucial for addressing age-related liver conditions. This study aims to fill the knowledge gap regarding the remodeling of hepatic immune cells during aging.

Data Highlights

Remove placeholder text and replace with relevant findings or state 'No data available.'

Key Findings

  • Significant reduction of IgD+ B cells in aged mouse livers.
  • Expansion of multiple CD4+ T cell subsets (Th1, Th2, Th17, Treg) in aged livers.
  • Increased presence of pro-inflammatory M1 macrophages in aged hepatic tissue.
  • Stable levels of CD8+ T cells and double-negative T cells in aged livers.
  • Downregulation of genes related to B cell migration and receptor binding in aged livers.

Clinical Implications

These findings suggest that age-related changes in hepatic immune cell populations may contribute to the increased incidence of liver diseases in older adults. Understanding these alterations can inform strategies for managing liver health in aging populations.

Conclusion

The study provides critical insights into the immune landscape of the aging liver, emphasizing the need for further research on the implications of these changes for chronic liver disease management.

References

  1. Basic Research in Cardiology, 2024 -- Mineralocorticoid Receptor's Role in Cardiac Macrophage Inflammaging
  2. npj Digital Medicine, 2026 -- Combining Multi-Omics Approaches with Machine Learning to Unravel Cellular Diversity and Fibrotic Regulatory Pathways in the Transition from MASLD to MASH
  3. Acta Neuropathologica, 2020 -- Rejuvenation of Macrophage/Microglia via Niacin Promotes Remyelination in the Aging Central Nervous System
  4. EASL–EASD–EASO Clinical Practice Guidelines, 2025 -- Executive Summary on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
  5. Hepatology, 2025 -- Critical Update on AASLD Practice Guidance
  6. Archives of Toxicology — Activity of Gene Networks in Cultured Primary Hepatocytes Closely Resembles That of Diseased Liver Tissue in Mammals
  7. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary - PMC
  8. Hepatology
  9. Recommended Adult Immunization Schedule for ages 19 years or older; 2025 U.S.

Original Source(s)

Related Content